|Articles|December 1, 1997

December 1997
Volume 3
Issue 12

Adverse Drug Reactions: A Review for Healthcare Practitioners

Author(s)Linda R. Young, PharmD, J. Douglas Wurtzbacher, PharmD, Crystal S. Blankenship, PharmD

Download PDF: Adverse Drug Reactions: A Review for Healthcare Practitioners

Articles in this issue

over 28 years ago

Article

Cost Implications of Selective Preoperative Screening in the Care of Candidates for Peripheral Vascular Operations

over 28 years ago

Article

Disease Management Interventions to Improve Outcomes in Congestive Heart Failure

over 28 years ago

Article

Sedating Effects of AM/PM Antihistamine Dosing with Evening Chlorpheniramine and Morning Terfenadine

over 28 years ago

Article

Physicians in Training as Quality Managers: Survival Strategy for Academic Health Centers

over 28 years ago

Article

Gastrointestinal Illness in Managed Care: Healthcare Utilization and Costs

over 28 years ago

Article

Recognition and Treatment of Patients in the Persistent Vegetative State

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Adverse Drug Reactions: A Review for Healthcare Practitioners

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Adverse Drug Reactions: A Review for Healthcare Practitioners

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment